rx 821002 has been researched along with potassium chloride in 2 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (potassium chloride) | Trials (potassium chloride) | Recent Studies (post-2010) (potassium chloride) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 18,040 | 395 | 1,764 |
| Protein | Taxonomy | rx 821002 (IC50) | potassium chloride (IC50) |
|---|---|---|---|
| Sodium/potassium/calcium exchanger 4 | Homo sapiens (human) | 174000 | |
| Sodium/potassium/calcium exchanger 2 | Homo sapiens (human) | 280000 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lafontan, M; Langin, D; Paris, H | 1 |
| Etgen, AM; Karkanias, GB | 1 |
2 other study(ies) available for rx 821002 and potassium chloride
| Article | Year |
|---|---|
Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Binding Sites; Brimonidine Tartrate; Cell Membrane; Cystamine; Dioxanes; Dioxins; Epinephrine; Female; Humans; Idazoxan; Magnesium Chloride; Phenoxybenzamine; Potassium Chloride; Quinoxalines; Tritium; Yohimbine | 1990 |
Estradiol attenuates alpha 2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium; Dioxanes; Estradiol; Female; Hypothalamus; Idazoxan; Norepinephrine; Ovariectomy; Potassium Chloride; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Yohimbine | 1993 |